Associative analysis of multi-omics data indicates that acetylation modification is widely involved in cigarette smoke-induced chronic obstructive pulmonary disease

Junyin Gao,Hongjun Liu,Xiaolin Wang,Liping Wang,Jianjun Gu,Yuxiu Wang,Zhiguang Yang,Yunpeng Liu,Jingjing Yang,Zhibin Cai,Yusheng Shu,Lingfeng Min
DOI: https://doi.org/10.3389/fmed.2022.1030644
IF: 3.9
2023-01-12
Frontiers in Medicine
Abstract:We aimed to study the molecular mechanisms of chronic obstructive pulmonary disease (COPD) caused by cigarette smoke more comprehensively and systematically through different perspectives and aspects and to explore the role of protein acetylation modification in COPD. We established the COPD model by exposing C57BL/6J mice to cigarette smoke for 24 weeks, then analyzed the transcriptomics, proteomics, and acetylomics data of mouse lung tissue by RNA sequencing (RNA-seq) and liquid chromatography-tandem mass spectrometry (LC-MS/MS), and associated these omics data through unique algorithms. This study demonstrated that the differentially expressed proteins and acetylation modification in the lung tissue of COPD mice were co-enriched in pathways such as oxidative phosphorylation (OXPHOS) and fatty acid degradation. A total of 19 genes, namely, ENO3, PFKM, ALDOA, ACTN2, FGG, MYH1, MYH3, MYH8, MYL1, MYLPF, TTN, ACTA1, ATP2A1, CKM, CORO1A, EEF1A2, AKR1B8, MB , and STAT1 , were significantly and differentially expressed at all the three levels of transcription, protein, and acetylation modification simultaneously. Then, we assessed the distribution and expression in different cell subpopulations of these 19 genes in the lung tissues of patients with COPD by analyzing data from single-cell RNA sequencing (scRNA-seq). Finally, we carried out the in vivo experimental verification using mouse lung tissue through quantitative real-time PCR (qRT-PCR), Western blotting (WB), immunofluorescence (IF), and immunoprecipitation (IP). The results showed that the differential acetylation modifications of mouse lung tissue are widely involved in cigarette smoke-induced COPD. ALDOA is significantly downregulated and hyperacetylated in the lung tissues of humans and mice with COPD, which might be a potential biomarker for the diagnosis and/or treatment of COPD.
medicine, general & internal
What problem does this paper attempt to address?
The problem this paper attempts to address is to comprehensively and systematically study the molecular mechanisms of chronic obstructive pulmonary disease (COPD) caused by smoking through multi-omics data association analysis, and to explore the role of protein acetylation modifications in COPD. Specifically, the researchers aim to: 1. **Elucidate the molecular mechanisms of COPD**: Reveal the molecular mechanisms of COPD from different levels such as gene transcription, protein translation, and post-translational modifications through transcriptomics, proteomics, and acetylomics data. 2. **Explore the role of protein acetylation modifications**: Investigate the extensive involvement and potential biological functions of protein acetylation modifications in COPD. 3. **Discover new prevention and treatment targets**: Identify new biomarkers and targets that may be used for the diagnosis and treatment of COPD through multi-omics data association analysis. 4. **Analyze the distribution of genes in different cell subpopulations**: Use single-cell RNA sequencing (scRNA-seq) technology to analyze the distribution of these genes in different cell subpopulations in the lung tissues of COPD patients, and select appropriate genes for subsequent experimental validation. In summary, this paper aims to comprehensively analyze the molecular mechanisms of COPD caused by smoking through multi-omics data association analysis, particularly the role of protein acetylation modifications, and to provide new ideas and targets for the prevention and treatment of COPD.